[{"Assets_0_Q3_USD":"462581000.0","CIK":"1023024","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"0.04","EarningsPerShareBasic_3_Q3_USD":"-1.58","EarningsPerShareDiluted_1_Q3_USD":"0.04","EarningsPerShareDiluted_3_Q3_USD":"-1.58","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","Market Cap":"569805985.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"20976000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":"422000.0","NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":"-18913000.0","NetIncomeLoss_1_Q3_USD":"434000.0","NetIncomeLoss_3_Q3_USD":"-18913000.0","OfficialName":"ANI Pharmaceuticals Inc.","RevenuesConverted_1_Q3_USD":"52979000.0","RevenuesConverted_3_Q3_USD":"151223000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q3_USD":"195100000.0","Ticker":"ANIP","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"12003000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"11953000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"11991000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"11953000.0","filed":"20201105","footnote":null,"form":"10-Q","fp":"Q3","fy":"2020.0","name":"ANI PHARMACEUTICALS INC","period":"20200930","qtrs":"3","uom":"USD"}]